3 a) A borderline significant association was found between mortality rate and higher levels of IL-6 when Tocilizumab was administered.
← all excerpts
Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2.
2
—
—
The sentences
Tocilizumab was administered in a dose of 8 mg/kg IV, if IL-6 levels were raised more than 10 times normal (> 70) and was repeated up to three times if the patient continued to be critical and the inflammatory markers remained persistently high or showed an increasing trend.